References
- World Health Organisation. Anthrax in humans and animals. 4th ed. Geneva: World Health Organization; 2008
- Bennett JE, Dolin R, Blaser MJ. Mandell, Douglas, and Bennett’s principles and practice of infectious diseases. Updated 8th ed. Philadelphia, PA: Elsevier Saunders; 2015:2391–2409
- Ghosh N, Goel AK. Anti-protective antigen IgG enzyme-linked immunosorbent assay for diagnosis of cutaneous anthrax in India. Clin Vaccine Immunol 2012;19:1238–42
- Quinn CP, Semenova VA, Elie CM, et al. Specific, sensitive, and quantitative enzyme-linked immunosorbent assay for human immunoglobulin G antibodies to anthrax toxin protective antigen. Emerg Infect Dis 2002;8:1103–10
- Quinn CP, Dull PM, Semenova V, et al. Immune responses to Bacillus anthracis protective antigen in patients with bioterrorism-related cutaneous or inhalation anthrax. J Infect Dis 2004;190:1228–36
- Baillie LW, Fowler K, Turnbull PC. Human immune responses to the UK human anthrax vaccine. J Appl Microbiol 1999;87:306–8
- Baillie LW, Huwar TB, Moore S, et al. An anthrax subunit vaccine candidate based on protective regions of Bacillus anthracis protective antigen and lethal factor. Vaccine 2010;28:6740–8
- Doganay M, Metan G. Human anthrax in Turkey from 1990 to 2007. Vector Borne Zoonotic Dis 2009;9:131–40
- Özden K, Özkurt Z, Erol S, et al. Cutaneous anthrax patients in Eastern Anatolia, Turkey: a review of 44 adults cases. Turk J Med Sci 2012;42:39–45
- Ozcan H, Kayabas U, Bayindir Y, et al. Evaluation of 23 cutaneous anthrax patients in eastern Anatolia, Turkey: diagnosis and risk factors. Int J Dermatol 2008;47:1033–7
- Harrison LH, Ezzell JW, Abshire TG, et al. Evaluation of serologic tests for diagnosis of anthrax after an outbreak of cutaneous anthrax in Paraguay. J Infect Dis 1989;160:706–10
- Sweeney DA, Hicks CW, Cui X, et al. Anthrax infection. Am J Respir Crit Care Med 2011;184:1333–41
- Oncül O, Ozsoy MF, Gul HC, et al. Cutaneous anthrax in Turkey: a review of 32 cases. Scand J Infect Dis 2002;34:413–16
- Ghosh N, Gunti D, Lukka H, et al. Development & validation of a quantitative anti-protective antigen IgG enzyme linked immunosorbent assay for serodiagnosis of cutaneous anthrax. Indian J Med Res 2015;142:196–204
- Ghosh N, Tomar I, Lukka H, Goel AK. Serodiagnosis of human cutaneous anthrax in India using an indirect anti-lethal factor IgG enzyme-linked immunosorbent assay. Clin Vaccine Immunol 2013;20:282–6
- Brenneman KE, Doganay M, Akmal A, et al. The early humoral immune response to Bacillus anthracis toxins in patients infected with cutaneous anthrax. FEMS Immunol Med Microbiol 2011;62:164–72
- Cohen S, Mendelson I, Altboum Z, et al. Attenuated nontoxinogenic and nonencapsulated recombinant Bacillus anthracis spore vaccines protect against anthrax. Infect Immun 2000;68:4549–58
- Ingram RJ, Metan G, Maillere B, et al. Natural exposure to cutaneous anthrax gives long-lasting T cell immunity encompassing infection-spesific epitopes. J Immunol 2010;184:3814–21